Fachrepositorium Lebenswissenschaften | Freier Zugang zu Wissensressourcen aus den Lebenswissenschaften

4 Treffer

Kurzansicht	E-Jahr	Zugriff	Typ	Operations
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial 2021 . Leypoldt, Lisa \| Besemer, Britta \| Asemissen, Anne Marie \| Hänel, Mathias \| Blau, Igor Wolfgang \| Görner, Martin \| Ko, Yon-Dschun \| Reinhardt, Hans Christian \| Staib, Peter \| Mann, Christoph \| Lutz, Raphael \| Munder, Markus \| Graeven, Ullrich \| Peceny, Rudolf \| Salwender, Hans \| Jauch, Anna \| Zago, Manola \| Benner, Axel \| Tichy, Diana \| Bokemeyer, Carsten \| Goldschmidt, Hartmut \| Weisel, Katja	2021		http://purl.org/ontology/bibo/Article
Selective elimination of immunosuppressive T cells in patients with multiple myeloma 2021 . Awwad, Mohamed H. S. \| Mahmoud, Abdelrahman \| Bruns, Heiko \| Echchannaoui, Hakim \| Kriegsmann, Katharina \| Lutz, Raphael \| Raab, Marc S. \| Bertsch, Uta \| Munder, Markus \| Jauch, Anna \| Weisel, Katja \| Maier, Bettina \| Weinhold, Niels \| Salwender, Hans Jürgen \| Eckstein, Volker \| Hänel, Mathias \| Fenk, Roland \| Dürig, Jan \| Brors, Benedikt \| Benner, Axel \| Müller-Tidow, Carsten \| Goldschmidt, Hartmut \| Hundemer, Michael	2021		http://purl.org/ontology/bibo/Article
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age 2020 . Mai, Elias Karl \| Miah, Kaya \| Bertsch, Uta \| Dürig, Jan \| Scheid, Christof \| Weisel, Katja C. \| Kunz, Christina \| Munder, Markus \| Lindemann, Hans-Walter \| Merz, Maximilian \| Hose, Dirk \| Jauch, Anna \| Seckinger, Anja \| Luntz, Steffen \| Sauer, Sandra \| Fuhrmann, Stephan \| Brossart, Peter \| Elmaagacli, Ahmet \| Goerner, Martin \| Bernhard, Helga \| Hoffmann, Martin \| Raab, Marc S. \| Blau, Igor W. \| Hänel, Mathias \| Benner, Axel \| Salwender, Hans J. \| Goldschmidt, Hartmut	2020		http://purl.org/ontology/bibo/Article
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk 2020 . Weisel, Katja \| Spencer, Andrew \| Lentzsch, Suzanne \| Avet-Loiseau, Hervé \| Mark, Tomer M. \| Spicka, Ivan \| Masszi, Tamas \| Lauri, Birgitta \| Levin, Mark-David \| Bosi, Alberto \| Hungria, Vania \| Cavo, Michele \| Lee, Je-Jung \| Nooka, Ajay \| Quach, Hang \| Munder, Markus \| Lee, Cindy \| Barreto, Wolney \| Corradini, Paolo \| Min, Chang-Ki \| Chanan-Khan, Asher A. \| Horvath, Noemi \| Capra, Marcelo \| Beksac, Meral \| Ovilla, Roberto \| Jo, Jae-Cheol \| Shin, Ho-Jin \| Sonneveld, Pieter \| Casneuf, Tineke \| DeAngelis, Nikki \| Amin, Himal \| Ukropec, Jon \| Kobos, Rachel \| Mateos, Maria-Victoria	2020		http://purl.org/ontology/bibo/Article